Reference
Pina JM, et al. Cost-effectiveness of rifampin for 4 months and isoniazid for 6 months in the treatment of tuberculosis infection. Respiratory Medicine : 13 Mar 2013. Available from: URL: http://dx.doi.org/10.1016/j.rmed.2013.01.017
Rights and permissions
About this article
Cite this article
Rifampicin cost-effective option for LTBI control. PharmacoEcon Outcomes News 674, 8 (2013). https://doi.org/10.1007/s40274-013-0252-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0252-6